Literature DB >> 20977934

Interictal alterations of cytokines and leukocytes in patients with active epilepsy.

Mareike Nowak1, Sebastian Bauer, Anja Haag, Sabine Cepok, Anelia Todorova-Rudolph, Björn Tackenberg, Braxton Norwood, Wolfgang H Oertel, Felix Rosenow, Bernhard Hemmer, Hajo M Hamer.   

Abstract

BACKGROUND: Involvement of the innate immune system in the pathogenesis of epilepsies has been suggested but possible interactions between the immune system and human epilepsy remain unclear. We analyzed the interictal immuno-phenotype of leukocyte subsets and proinflammatory cytokine profiles in epileptic patients and correlated them with the epilepsy syndrome.
METHODS: 101 patients with active focal or generalized epilepsy were prospectively included and compared to 36 healthy controls. Immuno-phenotype of leukocyte subsets and cytokines IL-1β, IL-6 and tnfα were measured in peripheral blood. Multivariate analyses were performed to test group differences.
RESULTS: As compared to controls, the patients showed an elevated percentage of monocytes (18.06±7.08% vs. 12.68±4.55%, p<0.001), NK cells (14.88±7.08% vs. 11.43±5.41%, p=0.019) and IL-6 concentration (3.33±3.11 pg/ml vs. 1.5±1.36 pg/ml, p=0.002). This remained true when focal epilepsies or generalized epilepsies were compared separately to controls but only focal epilepsies showed additionally a decrease in B lymphocyts (8.16±3.76% vs. 11.54±4.2%, p<0.001). Treatment with lamotrigine was associated with a higher percentage of B lymphocytes and valproate with an increased percentage of CD4(+) T lymphocytes. Therapy with levetiracetam showed a trend towards decreased CD8(+) T cell counts. No significant differences were seen between focal and generalized epilepsies and between temporal and extratemporal lobe epilepsies.
CONCLUSION: Patients with active epilepsy revealed interictal alterations of the immune system which varied among specific syndromes and were influenced by antiepileptic drug treatment.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977934     DOI: 10.1016/j.bbi.2010.10.022

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  17 in total

Review 1.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

3.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

Review 4.  Some cross-talks between immune cells and epilepsy should not be forgotten.

Authors:  Hong Wang; Sibo Liu; Zeyao Tang; Jinjie Liu
Journal:  Neurol Sci       Date:  2014-09-25       Impact factor: 3.307

5.  The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling.

Authors:  Francisco Garcia-Oscos; Humberto Salgado; Shawn Hall; Feba Thomas; George E Farmer; Jorge Bermeo; Luis Charles Galindo; Ruben D Ramirez; Santosh D'Mello; Stefan Rose-John; Marco Atzori
Journal:  Biol Psychiatry       Date:  2011-12-22       Impact factor: 13.382

6.  Sudden cardiac arrest in people with epilepsy in the community: Circumstances and risk factors.

Authors:  Robert J Lamberts; Marieke T Blom; Merel Wassenaar; Abdennasser Bardai; Frans S Leijten; Gerrit-Jan de Haan; Josemir W Sander; Roland D Thijs; Hanno L Tan
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 7.  Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.

Authors:  Alireza Soltani Khaboushan; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

Review 8.  Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner.

Authors:  Wenbin Liu; Meiyang Fan; Wen Lu; Wenhua Zhu; Liesu Meng; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 9.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

10.  Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro.

Authors:  Hubertus Himmerich; Stefanie Bartsch; Hajo Hamer; Roland Mergl; Jeremias Schönherr; Charlotte Petersein; Alexander Munzer; Kenneth Clifford Kirkby; Katrin Bauer; Ulrich Sack
Journal:  Oxid Med Cell Longev       Date:  2014-03-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.